POZZI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 7.535
EU - Europa 3.851
AS - Asia 3.447
SA - Sud America 576
Continente sconosciuto - Info sul continente non disponibili 374
AF - Africa 272
OC - Oceania 17
Totale 16.072
Nazione #
US - Stati Uniti d'America 7.291
SG - Singapore 1.227
IT - Italia 1.145
VN - Vietnam 717
CN - Cina 592
RU - Federazione Russa 533
BR - Brasile 456
UA - Ucraina 382
HK - Hong Kong 340
DE - Germania 306
FR - Francia 257
IE - Irlanda 247
FI - Finlandia 226
SE - Svezia 219
CI - Costa d'Avorio 159
DK - Danimarca 140
TR - Turchia 133
GB - Regno Unito 124
CA - Canada 105
IN - India 102
KR - Corea 84
NL - Olanda 81
BD - Bangladesh 58
AT - Austria 51
ZA - Sudafrica 47
AR - Argentina 42
MX - Messico 41
MA - Marocco 29
PL - Polonia 28
ES - Italia 27
CR - Costa Rica 24
ID - Indonesia 24
IQ - Iraq 22
EC - Ecuador 21
JP - Giappone 21
RO - Romania 18
AU - Australia 16
LT - Lituania 16
PH - Filippine 15
VE - Venezuela 15
PK - Pakistan 14
BE - Belgio 13
CL - Cile 13
UZ - Uzbekistan 13
CO - Colombia 12
CW - ???statistics.table.value.countryCode.CW??? 12
JM - Giamaica 12
HN - Honduras 10
TH - Thailandia 10
SA - Arabia Saudita 9
IL - Israele 8
TT - Trinidad e Tobago 8
PR - Porto Rico 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
GP - Guadalupe 6
GT - Guatemala 6
JO - Giordania 6
KE - Kenya 6
SV - El Salvador 6
AL - Albania 5
AZ - Azerbaigian 5
DZ - Algeria 5
HR - Croazia 5
MY - Malesia 5
PA - Panama 5
PY - Paraguay 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
EU - Europa 4
LB - Libano 4
NI - Nicaragua 4
PE - Perù 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
LC - Santa Lucia 2
SM - San Marino 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
Totale 15.689
Città #
Ashburn 1.159
Singapore 750
Dallas 713
San Jose 480
Chandler 422
Council Bluffs 410
Jacksonville 386
Hong Kong 327
Dublin 241
Boardman 237
Ho Chi Minh City 222
New York 205
Fairfield 204
Hanoi 166
Abidjan 159
Los Angeles 153
Wilmington 152
Beijing 133
The Dalles 121
Helsinki 117
Marche 113
Lauterbourg 100
Des Moines 99
Houston 88
Princeton 86
Seattle 86
Lawrence 85
Moscow 85
Milan 83
San Mateo 80
Ancona 74
Munich 74
Ann Arbor 69
Orem 65
Woodbridge 62
Hefei 60
Cambridge 59
Santa Clara 57
Turin 53
Buffalo 52
São Paulo 48
Da Nang 44
Chicago 40
Turku 39
Chennai 38
Centro 37
Haiphong 36
San Diego 36
Phoenix 35
Vienna 34
Rome 32
Shanghai 30
Amsterdam 29
Johannesburg 29
Montreal 28
London 27
Tolentino 27
Recanati 26
Brooklyn 25
Washington 25
Atlanta 24
Denver 24
Nuremberg 24
Stockholm 23
Naples 20
San José 20
Wuhan 20
Mexico City 18
Tokyo 18
Warsaw 17
Manchester 16
Redmond 16
Ankara 15
Berlin 15
Boston 15
Aversa 14
Guangzhou 14
Iesi 14
Poplar 14
San Francisco 14
Belo Horizonte 13
Brussels 13
Curitiba 13
Pavia 13
Toronto 13
Brasov 12
Frankfurt am Main 12
Salt Lake City 12
Willemstad 12
Biên Hòa 11
Hải Dương 11
Quito 11
Rio de Janeiro 11
Tashkent 11
Civitanova Marche 10
Mumbai 10
Pune 10
Wuxi 10
Baghdad 9
Delhi 9
Totale 9.533
Nome #
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 225
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 220
Paraoxonase-2 in osteosarcoma: potential for the development of a targeted anticancer therapy 209
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 200
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 193
Clinical performance and utility of a NNMT-based urine test for bladder cancer 192
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 191
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 186
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 184
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 184
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 183
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 183
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 181
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 177
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 177
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 175
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 173
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 169
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 169
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 168
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 167
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 167
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 166
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 165
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 164
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 163
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 163
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 163
Inflammatory cytokines pattern in recurrent miscarriage. 162
Involvement of the oral cavity in psoriasis: results of a clinical study 159
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 158
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 157
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 156
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 155
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 152
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 150
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 150
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 146
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 144
Enhancing cisplatin efficacy in triple-negative breast cancer through pon2 silencing: insights from FTIRM analysis 143
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 143
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 143
Treatment of osteosarcoma and Merkel cell carcinoma cell lines with inhibitors of nicotinamide N-methyltransferase: potential for the development of targeted therapeutic strategy 142
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 141
Paraoxonase-2 expression in oral squamous cell carcinoma 140
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 139
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 137
FTIR Imaging as a new tool for investigating oral tongue squamous cell carcinoma 135
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 135
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 133
Inflammatory cytokines pattern in recurrent miscarriage. 132
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 132
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 131
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 131
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 131
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 130
Catecholamine O-Methyltransferase as a Promising Diagnostic and Therapeutic Target in Oral Squamous Cell Carcinoma 130
CSCs selection, characterization and tumorigenic potential in OSCC. 130
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 129
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 127
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 126
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 126
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 126
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 125
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 125
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 125
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 125
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 123
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 123
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 123
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 122
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 120
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 120
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 118
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 117
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 115
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 115
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 115
Enhanced expression of paraoxonase 2 in human bladder cancer 113
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 111
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 110
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 109
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 108
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 108
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 107
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 106
Espressione di Pokemon nel carcinoma orale. 106
Paraoxonase 2 (PON2) expression in bladder cancer 105
Urinary Cell-Free DNA as a potential diagnostic biomarker for bladder cancer in older adults 104
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 104
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 104
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 104
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 103
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 103
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 101
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 99
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 99
Nicotinamide N-Methyltransferase as potential predictor of lymph node metastasis in Oral Squamous Cell Carcinoma. 99
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 98
The Effect and the Potential Use of Magnetic–Dam Barrier in Guided Bone Regeneration: A Laboratory Study 97
Totale 14.067
Categoria #
all - tutte 70.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022418 0 0 0 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/20252.146 287 144 101 46 108 30 185 74 400 153 251 367
2025/20266.599 540 382 734 658 711 433 1.129 555 531 541 185 200
2026/20271.735 274 294 466 701 0 0 0 0 0 0 0 0
Totale 16.072